Immune Activation and Deficit in Neurotransmitters Synthesis in Treatment Resistant Depression: About a Case of Hashimoto Encephalopathy

다국어 초록 (Multilingual Abstract)

We report a case of Hashimoto encephalopathy initially presented as a drug-resistant depression with predominant apathy and asthenia, successfully treated with cyclophosphamide. We suspected that the psychiatric symptoms were due to a deficit in neurotransmitter synthesis related to immune activation. We hypothesized that the immunomodulatory treatment helped to restore the neurotransmitter synthesis and thus decreased the patient’s depressive symptoms. In this case report we propose an innovative model in which immunity might disturbs neurotransmitters synthesis leading to depressive symptoms.

참고문헌 (Reference)

1 Chamberlain SR, "Treatment-resistant depression and peripheral C-reactive protein" 214 : 11-19, 2019

2 McIntyre RS, "Treatment-resistant depression : definitions, review of the evidence, and algorithmic approach" 156 : 1-7, 2014

3 Saygi S, "Tic disorder probably associated with steroid responsive encephalopathy with autoimmune thyroiditis(SREAT)" 81 : 1105-1107, 2014

4 Miller AH, "The role of inflammation in depression : from evolutionary imperative to modern treatment target" 16 : 22-34, 2016

5 Stein DJ, "Stress, depression, and inflammation : molecular and microglial mechanisms" 83 : 5-6, 2018

6 Laurent C, "Steroid-responsive encephalopathy associated with autoimmune thyroiditis(SREAT) : characteristics, treatment and outcome in 251 cases from the literature" 15 : 1129-1133, 2016

7 Endres D, "Steroid-responsive chronic schizophreniform syndrome in the context of mildly increased antithyroid peroxidase antibodies" 8 : 64-, 2017

8 Dantzer R, "Role of the kynurenine metabolism pathway in inflammation-induced depression : preclinical approaches" 31 : 117-138, 2017

9 Felger JC, "Risk and resilience : animal models shed light on the pivotal role of inflammation in individual differences in stress-induced depression" 78 : 7-9, 2015

10 Ampélas JF, "Psychiatric manifestations of lupus erythematosus systemic and Sjogren’s syndrome" 27 : 588-599, 2001

11 Wohleb ES, "Integrating neuroimmune systems in the neurobiology of depression" 17 : 497-511, 2016

12 Remus JL, "Inflammation models of depression in rodents: relevance to psychotropic drug discovery" 19 : pyw028-, 2016

13 Strawbridge R, "Inflammation and clinical response to treatment in depression : a meta-analysis" 25 : 1532-1543, 2015

14 Kiecolt-Glaser JK, "Inflammation : depression fans the flames and feasts on the heat" 172 : 1075-1091, 2015

15 de Holanda NC, "Hashimoto’s encephalopathy : systematic review of the literature and an additional case" 23 : 384-390, 2011

16 Zhou JY, "Hashimoto encephalopathy : literature review" 135 : 285-290, 2017

17 Olmez I, "Diagnostic and therapeutic aspects of Hashimoto’s encephalopathy" 331 : 67-71, 2013

18 Dantzer R, "Depression and inflammation : an intricate relationship" 71 : 4-5, 2012

19 Bonnet U, "Delirious mania associated with autoimmune gastrothyroidal syndrome of a mid-life female : the role of Hashimoto encephalopathy and a 3-year follow-up including serum autoantibody levels" 2016 : 4168050-, 2016

20 Chung HY, "Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: a case report" 98 : e15706-, 2019

21 Mariotto S, "Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease" 6 : 38-43, 2014

22 Graus F, "A clinical approach to diagnosis of autoimmune encephalitis" 15 : 391-404, 2016